Abstract:Background: Acute lung injury caused by renal ischemia-reperfusion is one of the leading causes of acute kidney injury-related death. Dexmedetomidine, an alpha(2)-adrenergic agonist sedative, has been found to have protective effects against acute kidney injury and remote lung injury. We sought to determine whether dexmedetomidine can exert its anti-apoptotic effects in acute lung injury after acute kidney injury, in addition to its common anti-inflammatory effects, and to determine the underlying mechanisms.Methods: In vivo, acute kidney injury was induced by 60 min of kidney ischemia (bilateral occlusion of renal pedicles) followed by 24 h of reperfusion. Mice received dexmedetomidine (25 mu g/kg, i.p.) in the absence or presence of alpha(2)-adrenergic antagonist atipamezole (250 mu g/kg, i.p.) before IR. Histological assessment of the lung was conducted by HE staining and arterial blood gases were measured. Lung apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay. The expression of caspase 3 and p-Akt in lung tissue was detected by western blot. In vitro, C57BL/6J mice pulmonary microvascular endothelial cells were treated with serum from mice obtained following sham or IR. Dexmedetomidine was given before serum stimulation in cells, alone or with atipamezole or LY294002. Cell viability was assessed by CCK 8 assay. Cell apoptosis was examined by Hoechst staining and Annexin V-FITC/PI staining flow cytometry analysis. Mitochondrial membrane potential was measured by flow cytometry. The expression of p-Akt, caspase 3, Bcl-2 and Bax was measured by western blot.Results: In vivo, dexmedetomidine remarkably mitigated pathohistological changes and apoptosis and significantly increased p-Akt expression in the lung. In addition, dexmedetomidine also slightly improved oxygenation in mice after IR, which can be abolished by atipamezole. In vitro, dexmedetomidine significantly inhibited IR serum-induced loss of viability and apoptosis in PMVECs. Dexmedetomidine increased p-Akt in a time-and dose-dependent manner, and down-regulated the expression of caspase 3 and Bax and up-regulated the Bcl-2 expression in PMVECs. The changes of MMP were also improved by dexmedetomidine. Whilst these effects were abolished by Atipamezole or LY294002.Conclusion: Our results demonstrated that dexmedetomidine attenuates lung apoptosis induced by IR, at least in part, via alpha(2)AR/PI3K/Akt pathway.

Pré‐condicionamento Com Dexmedetomidina Protege Contra Lesão Pulmonar Em Ratos Com Choque Hemorrágico

[Dexmedetomidine Preconditioning Protects Against Lung Injury in Hemorrhagic Shock Rats].

[Dexmedetomidine Preconditioning Protects Against Lipopolysaccharides-Induced Injury in the Human Alveolar Epithelial Cells].

Pré‐condicionamento Com Dexmedetomidina Protege Contra Lesões Induzidas Por Lipopolissacarídeos Em Células Epiteliais Alveolares Humanas

Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion

Protective effects of dexmedetomidine preconditioning in rats with myocardial ischemia reperfusion injury and the effects on calcium regulatory proteins

Protective effects of dexmedetomidine on blunt chest traumaYinduced pulmonary contusion in rats

The Protective Mechanism of Dexmedetomidine on Renal in Hemorrhagic Shock

Effects of Dexmedetomidine on NLRP3 Inflammasome During Acute Lung Injury Induced by Blunt Chest Trauma and Hemorrhagic Shock-Resuscitation in Rats

Dexmedetomidine Alleviates Blunt Chest Trauma and Hemorrhagic Shock‑resuscitation‑induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome.

Dose-response and Mechanism of Protective Functions of Selective Alpha-2 Agonist Dexmedetomidine on Acute Lung Injury in Rats.

The Effects of Dexmedetomidine Preconditioning on Aged Rat Heart of Ischaemia Reperfusion Injury

Effects of Dexmedetomidine on Global Cerebral Ischemia-Reperfusion Injury in Rats

Effect of Dexmedetomidine on Serum Concentrations of TNF-α and IL-1β in Acute Lung Injury Following Blunt Chest Trauma in Rats

Effects Of Dexmedetomidine Pretreatment On Tnf-Alpha And Il-6, Oxidative Stress And Myocardial Apoptosis Of Rats After Myocardial Ischemia-Reperfusion Injury

Dexmedetomidine postconditioning attenuates cerebral ischemia following asphyxia cardiac arrest through down-regulation of apoptosis and neuroinflammation in rats

Dexmedetomidine Attenuates Lung Apoptosis Induced By Renal Ischemiareperfusion Injury Through Alpha(2)Ar/Pi3k/Akt Pathway

Effect of Different Doses of Dexmedetomidine on Lung Function and Tissue Cell Apoptosis in a Rat Model of Hyperoxic Acute Lung Injury

Dexmedetomidine Attenuates Renal and Myocardial Ischemia/Reperfusion Injury in a Dose-Dependent Manner by Inhibiting Inflammatory Response.

Effect of dexmedetomidine on myocardial ischemia-reperfusion injury in rats

Dexmedetomidine post-conditioning attenuates cerebral ischemia following asphyxia cardiac arrest through down-regulation of apoptosis and neuroinflammation in rats